Table 5

Influence of smoking and sex on type, site, and extent of familial inflammatory bowel disease.

Smokers at diagnosis
Females (n=151)Males (n=98)
Values are odds ratios (95% confidence limits).
Patients were stratified by diagnosis, sex, and smoking habit. Female smokers at diagnosis were compared with female non-smoking relatives. Male smokers at diagnosis were compared with male non-smoking relatives. Female smokers were significantly more likely to develop Crohn's disease (CD) (p<0.001), particularly with colonic involvement (p=0.003), and less likely to develop ulcerative colitis (UC) (p<0.001) than male smokers (*p<0.05, **p<0.005, ***p<0.0001).
CD5.44 (3.33–8.88)*** n=1222.11 (1.26–3.52)** n=58
    Ileal disease1.38 (0.71–2.71) n=943.68 (1.42–9.52)** n=49
    Ileo-caecal disease1.86 (0.92–3.77) n=991.54 (0.47–5.02) n=51
    Colonic disease1.17 (0.66–2.1) n=680.27 (0.13–0.58)** n=19
    Fibrostenosing disease1.83 (1.03–3.24)* n=752.49 (1.17–5.29)* n=38
    Perforating disease0.99 (0.51–1.91) n=281.07 (0.44–2.58) n=12
    Intestinal resection2.12 (1.17–3.86)* n=961.47 (0.69–3.13) n=38
UC0.18 (0.11–0.3)*** n=290.47 (0.28–0.79)** n=40
    Pancolitis1.34 (0.59–3.04) n=161.21 (0.58–2.55) n=20
    Colectomy0.95 (0.38–2.35) n=81.06 (0.44–2.59) n=9